SeaStar Medical (NASDAQ:ICU) versus Merit Medical Systems (NASDAQ:MMSI) Financial Review

Merit Medical Systems (NASDAQ:MMSI) and SeaStar Medical (NASDAQ:ICU) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

Risk and Volatility

Merit Medical Systems has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.08, suggesting that its share price is 208% less volatile than the S&P 500.

Earnings & Valuation

This table compares Merit Medical Systems and SeaStar Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.26 billion	4.69	$94.41 million	$2.04	49.61
SeaStar Medical	N/A	N/A	-$26.23 million	($19.78)	-0.10

Merit Medical Systems has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 3.7% of Merit Medical Systems shares are owned by company insiders. Comparatively, 2.1% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and price targets for Merit Medical Systems and SeaStar Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0	2	9	1	2.92
SeaStar Medical	0	0	0	0	0.00

Merit Medical Systems currently has a consensus target price of $103.36, suggesting a potential upside of 2.14%. Given Merit Medical Systems’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Merit Medical Systems is more favorable than SeaStar Medical.

Profitability

This table compares Merit Medical Systems and SeaStar Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.05%	15.61%	8.38%
SeaStar Medical	N/A	N/A	-666.82%

Summary

Merit Medical Systems beats SeaStar Medical on 14 of the 14 factors compared between the two stocks.

About Merit Medical Systems

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.